CTNMNasdaq United States
Market cap
$565.822 M
$15.04 -2.02%
Close of 7 Aug 2026
Revenue
$0.00
#3658 by revenue
Earnings
-$60.0M
Loss-making
Shares outstanding
23,099,173
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Contineum Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.